Eyebright Competitors

688050 Stock

90.61 1.90 2.05%

Eyebright Medical competes with Great Sun, SUNSEA Telecommunicatio, Guangdong Shenglu, Guangxi Wuzhou, and Jiahe Foods; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Eyebright Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eyebright Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Eyebright Medical Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Eyebright Medical competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
88.54	92.74	96.94

Details

Intrinsic

Valuation

Low	Real	High
87.90	92.10	96.30

Details

Earnings

Estimates (0)

Low	Projected EPS	High
0.00	0.00	0.00

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eyebright Medical. Your research has to be compared to or analyzed against Eyebright Medical's peers to derive any actionable benefits. When done correctly, Eyebright Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eyebright Medical.

Eyebright Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eyebright Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eyebright and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eyebright Medical does not affect the price movement of the other competitor.

	603336	002313	002446	600368	605300	603697	601698	603057
603336		0.87	0.92	0.49	0.63	0.8	0.74	0.57	603336
002313	0.87		0.83	0.69	0.71	0.78	0.71	0.66	002313
002446	0.92	0.83		0.51	0.7	0.82	0.84	0.71	002446
600368	0.49	0.69	0.51		0.55	0.63	0.55	0.62	600368
605300	0.63	0.71	0.7	0.55		0.77	0.7	0.81	605300
603697	0.8	0.78	0.82	0.63	0.77		0.87	0.73	603697
601698	0.74	0.71	0.84	0.55	0.7	0.87		0.71	601698
603057	0.57	0.66	0.71	0.62	0.81	0.73	0.71		603057
	603336	002313	002446	600368	605300	603697	601698	603057

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Eyebright Stock performing well and Eyebright Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eyebright Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
603336	3.21	0.60	0.15	1.05	3.63	(3.56)	8.72	(6.29)	19.60
002313	3.63	0.67	0.14	2.68	3.93	(4.17)	10.01	(8.47)	20.09
002446	2.49	0.44	0.12	30.29	3.01	(2.72)	5.22	(5.72)	18.81
600368	2.03	0.87	0.29	16.86	2.07	(2.35)	6.93	(2.32)	18.97
605300	2.75	0.44	0.13	0.70	3.04	(3.20)	9.39	(5.41)	20.00
603697	3.10	1.04	0.29	1.17	2.71	(3.47)	8.64	(4.73)	17.03
601698	3.33	0.68	0.17	0.67	3.61	(3.92)	9.98	(7.71)	20.00
603057	2.54	0.35	0.12	0.39	2.53	(3.07)	6.50	(3.58)	18.04

Cross Equities Net Income Analysis

Compare Eyebright Medical and related stocks such as Great Sun Foods, SUNSEA Telecommunicatio, and Guangdong Shenglu Net Income Over Time

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
603336	60.6 M	60.6 M	60.6 M	60.6 M	60.6 M	60.6 M	60.6 M	63.3 M	64.2 M	79 M	73.2 M	47 M	47.4 M	24 M	45.9 M
002313	23 M	145.5 M	171.4 M	52 M	12.1 M	(28.9 M)	67.5 M	102 M	71.7 M	52.4 M	(720.5 M)	(244.7 M)	(1.3 B)	(364.5 M)	(346.3 M)
002446	28.9 M	12.1 M	10 M	4.5 M	48.2 M	121.3 M	161.4 M	100.8 M	121.1 M	(756.5 M)	181.2 M	(212.1 M)	243.7 M	52.4 M	55 M
600368	83 M	243.3 M	316.9 M	191.8 M	73.4 M	(95.6 M)	222.2 M	367.7 M	424.1 M	877.7 M	564.3 M	701.7 M	581.8 M	660.7 M	693.7 M
605300	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	271.5 M	215.9 M	150.7 M	115.4 M	257.8 M	161.8 M
603697	122.5 M	122.5 M	122.5 M	122.5 M	122.5 M	122.5 M	122.5 M	190.3 M	178.2 M	179.1 M	225.8 M	219.8 M	153.6 M	116.2 M	138.6 M
601698	437.6 M	437.6 M	437.6 M	437.6 M	437.6 M	437.6 M	437.6 M	389.5 M	418.3 M	446.4 M	488.8 M	572.3 M	922.8 M	348.8 M	553.4 M
603057	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	358.7 M	327.6 M	221.8 M	331.6 M	247.9 M

Eyebright Medical and related stocks such as Great Sun Foods, SUNSEA Telecommunicatio, and Guangdong Shenglu Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Eyebright Medical financial statement analysis. It represents the amount of money remaining after all of Eyebright Medical Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Eyebright Medical Competitive Analysis

The better you understand Eyebright Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eyebright Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eyebright Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	688050	603336	002313	002446	600368	605300	603697	601698	603057
	2.05 90.61 Eyebright	2.47 4.34 Great	5.01 8.16 SUNSEA	2.89 6.72 Guangdong	1.97 5.70 Guangxi	1.41 13.68 Jiahe	4.07 10.14 Youyou	1.21 21.20 China	0.59 18.80 Shanghai
Market Volatility (90 Days Market Risk)	Very steady	Relatively risky	Slightly risky	Slightly risky	Slightly risky	Somewhat reliable	Somewhat reliable	Not too volatile	Not too volatile
Market Performance (90 Days Performance)	Modest	OK	OK	OK	Solid	OK	Solid	OK	Modest
Odds of Financial Distress (Probability Of Bankruptcy)	Very Small	Very Low	Above Average	Low	Low	Low	Very Small	Low	Low
Current Valuation (Equity Enterprise Value)	Fairly Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Fairly Valued	Under Valued	Fairly Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Cautious Hold	Hold	Strong Sell	Strong Sell	Strong Hold	Strong Hold	Strong Buy	Cautious Hold	Strong Buy
Net Asset	3.06 B	1.84 B	3.65 B	4.26 B	9.46 B	3.2 B	1.98 B	22.66 B	2.9 B
Profit Margin	0.27	0.0096	-0.0875	-0.0426	0.41	0.0741	0.12	0.17	0.0991
EBITDA	506.62 M	67.06 M	(25.29 M)	140.35 M	1.06 B	288.07 M	149.27 M	1.67 B	415.43 M
Operating Margin	0.33	0.0458	-0.0086	0.12	0.53	0.0607	0.14	0.16	0.17
Current Valuation	16.91 B	3.14 B	4.64 B	5.74 B	9.22 B	4.46 B	3.54 B	84.7 B	6.58 B
Price To Book	7.2	2.16	27.04	1.93	1.21	2.45	2.54	5.79	3.75
Retained Earnings	647.18 M	434.22 M	(2.12 B)	42.33 M	3.96 B	956.85 M	900.97 M	2.8 B	819.26 M
Beta	0.52	0.1	0.97	-0.15	0.4	0.62	0.27	0.76	0.8
Number Of Employees	2.07 K	753	2.01 K	1.43 K	827	998	1.19 K	593	2 K
Shares Outstanding	189.54 M	570.39 M	374.4 M	915.32 M	1.61 B	400.01 M	427.69 M	4.22 B	414.26 M
Cash Flow From Operations	212.62 M	(3.49 M)	(181.3 M)	135.14 M	987.78 M	294.25 M	(3.95 M)	1.79 B	554.31 M
Annual Yield	0.0055	N/A	N/A	N/A	N/A	0.0204	N/A	N/A	0.0579
Total Debt	117.94 M	398.1 M	1.72 B	122.47 M	120 M	553.84 M	147.01 M	10 M	59.81 M
Return On Equity	0.15	0.0066	-0.93	-0.0136	0.1	0.0896	0.0728	0.0277	0.17
Return On Asset	0.0872	0.0122	-0.016	0.0103	0.0474	0.0437	0.0383	0.014	0.064
Book Value Per Share	12.29	2.06	0.33	3.59	4.19	5.42	4.16	3.71	4.82
Total Asset	3.06 B	1.84 B	3.65 B	4.26 B	9.46 B	3.2 B	1.98 B	22.66 B	2.9 B
Target Price	115.8	21.54	34.4	12.6	9.4	11.5	14.0	N/A	23.88
Last Dividend Paid	0.27	N/A	N/A	N/A	0.11	0.28	0.25	0.025	1.1
Shares Owned By Institutions	20.78	1.73	4.69	6.55	1.48	0.2	1.73	2.49	1.4
Market Capitalization	17.53 B	2.45 B	3.2 B	6.13 B	9 B	5.4 B	4.31 B	90.06 B	7.74 B
Price To Sales	12.91	2.32	1.04	5.86	5.39	2.09	3.94	35.85	2.26
Net Income	304.43 M	23.95 M	(364.53 M)	52.39 M	660.67 M	257.75 M	116.16 M	348.77 M	331.57 M
Earnings Per Share	1.95	0.01	-0.72	-0.05	0.32	0.33	0.3	0.1	0.82
Shares Owned By Insiders	38.48	51.94	46.64	14.62	56.9	89.4	73.3	85.21	87.3
Revenue	951.18 M	1.09 B	2.82 B	1.19 B	1.63 B	2.84 B	966.21 M	2.62 B	3.55 B
Working Capital	645.1 M	672.27 M	(906 M)	1.65 B	424.63 M	1.27 B	1.33 B	6.13 B	962.69 M
Gross Profit	491.15 M	102.51 M	229.27 M	556.9 M	975.99 M	326.04 M	389.76 M	990.5 M	575.56 M
Day Typical Price	91.34	4.35	8.23	6.74	5.75	13.63	10.2	21.32	18.66
Accumulation Distribution	42860.75	608270.0	1.3 M	971220.0	17.6 M	272757.0	539696.0	634240.0	202657.0
Daily Balance Of Power	(0.60)	(0.50)	(0.75)	(0.65)	0.1964	0.2	(0.58)	(0.46)	0.1507
Period Momentum Indicator	(1.90)	(0.11)	(0.43)	(0.20)	0.11	0.19	(0.43)	(0.26)	0.11
Rate Of Daily Change	0.98	0.98	0.95	0.97	1.02	1.01	0.96	0.99	1.01
Day Median Price	91.7	4.35	8.27	6.76	5.77	13.61	10.23	21.38	18.6
Price Action Indicator	(2.04)	(0.07)	(0.32)	(0.14)	(0.01)	0.17	(0.30)	(0.31)	0.26
Relative Strength Index	48.5	51.08	54.94	53.26	64.4	49.17	54.24	52.35	47.61
Coefficient Of Variation	1493.55	670.04	704.49	753.79	352.99	792.82	375.28	618.84	849.99
Mean Deviation	3.2	3.21	3.63	2.49	2.03	2.75	3.1	3.33	2.54
Jensen Alpha	0.2621	0.6012	0.6694	0.4357	0.875	0.4429	1.04	0.6795	0.3471
Total Risk Alpha	0.0934	0.4379	0.4676	0.2901	0.7408	0.3021	0.8939	0.5214	0.2364
Sortino Ratio	0.0739	0.15	0.1433	0.1172	0.2884	0.1281	0.2862	0.1652	0.1233
Downside Variance	11.42	15.33	20.17	11.73	8.53	11.33	13.08	17.06	7.86
Standard Deviation	4.4	4.23	4.85	3.36	3.13	3.77	4.05	4.5	3.32
Kurtosis	2.06	0.2064	0.2858	0.97	3.66	1.32	0.1982	0.4284	1.35
Potential Upside	8.39	8.72	10.01	5.22	6.93	9.39	8.64	9.98	6.5
Treynor Ratio	0.4392	1.05	2.68	30.29	16.86	0.6994	1.17	0.6667	0.3942
Maximum Drawdown	25.04	19.6	20.09	18.81	18.97	20.0	17.03	20.0	18.04
Variance	19.36	17.92	23.51	11.31	9.8	14.25	16.43	20.23	11.02
Market Risk Adjusted Performance	0.4492	1.06	2.69	30.3	16.87	0.7094	1.18	0.6767	0.4042
Risk Adjusted Performance	0.0617	0.1274	0.1218	0.1137	0.234	0.1087	0.2211	0.1374	0.1017
Skewness	1.08	0.1691	0.133	(0.02)	0.4644	0.3512	0.2513	0.0052	0.353
Semi Deviation	2.99	3.63	3.93	3.01	2.07	3.04	2.71	3.61	2.53
Information Ratio	0.0568	0.1387	0.1327	0.1194	0.269	0.1143	0.2554	0.1516	0.1042
Value At Risk	(5.45)	(6.29)	(8.47)	(5.72)	(2.32)	(5.41)	(4.73)	(7.71)	(3.58)
Expected Short fall	(3.78)	(3.56)	(4.17)	(2.72)	(2.35)	(3.20)	(3.47)	(3.92)	(3.07)
Downside Deviation	3.38	3.91	4.49	3.43	2.92	3.37	3.62	4.13	2.8
Semi Variance	8.95	13.2	15.44	9.08	4.27	9.23	7.34	13.02	6.4

Eyebright Medical Competition Performance Charts

Five steps to successful analysis of Eyebright Medical Competition

Eyebright Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eyebright Medical in relation to its competition. Eyebright Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Eyebright Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eyebright Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eyebright Medical, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eyebright Medical position

In addition to having Eyebright Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management

Major hospitals and healthcare providers. The Health Management theme has 41 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Eyebright Stock

Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyebright Competitors

Specify up to 10 symbols:

Eyebright Medical Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Eyebright Medical and related stocks such as Great Sun Foods, SUNSEA Telecommunicatio, and Guangdong Shenglu Net Income description

Eyebright Medical Competitive Analysis

Eyebright Medical Competition Performance Charts

Five steps to successful analysis of Eyebright Medical Competition

Complement your Eyebright Medical position

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management

Other Information on Investing in Eyebright Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY